Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

Condition:   Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma Intervention:   Drug: ME-401 Sponsor:   Kyowa Hakko Kirin Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials